Onyx Biotec Limited (NSE:ONYX)

Onyx Biotec Statistics

Total Valuation

Onyx Biotec has a market cap or net worth of INR 830.45 million. The enterprise value is 868.90 million.

Market Cap	830.45M
Enterprise Value	868.90M

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Onyx Biotec has 18.13 million shares outstanding. The number of shares has increased by 25.78% in one year.

Current Share Class	18.13M
Shares Outstanding	18.13M
Shares Change (YoY)	+25.78%
Shares Change (QoQ)	+25.27%
Owned by Insiders (%)	65.90%
Owned by Institutions (%)	n/a
Float	5.91M

Valuation Ratios

The trailing PE ratio is 13.88.

PE Ratio	13.88
Forward PE	n/a
PS Ratio	1.32
PB Ratio	1.49
P/TBV Ratio	1.49
P/FCF Ratio	229.34
P/OCF Ratio	58.61
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.55, with an EV/FCF ratio of 239.96.

EV / Earnings	17.54
EV / Sales	1.38
EV / EBITDA	7.55
EV / EBIT	10.27
EV / FCF	239.96

Financial Position

The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.22.

Current Ratio	1.91
Quick Ratio	1.12
Debt / Equity	0.22
Debt / EBITDA	1.08
Debt / FCF	34.40
Interest Coverage	4.26

Financial Efficiency

Return on equity (ROE) is 12.31% and return on invested capital (ROIC) is 8.55%.

Return on Equity (ROE)	12.31%
Return on Assets (ROA)	6.40%
Return on Invested Capital (ROIC)	8.55%
Return on Capital Employed (ROCE)	12.92%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.76
Inventory Turnover	3.11

Taxes

In the past 12 months, Onyx Biotec has paid 15.24 million in taxes.

Income Tax	15.24M
Effective Tax Rate	23.52%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	48.78
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.83
Average Volume (20 Days)	34,300

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Onyx Biotec had revenue of INR 631.19 million and earned 49.54 million in profits. Earnings per share was 3.30.

Revenue	631.19M
Gross Profit	239.87M
Operating Income	84.64M
Pretax Income	64.78M
Net Income	49.54M
EBITDA	115.11M
EBIT	84.64M
Earnings Per Share (EPS)	3.30

Balance Sheet

The company has 86.12 million in cash and 124.58 million in debt, giving a net cash position of -38.46 million or -2.12 per share.

Cash & Cash Equivalents	86.12M
Total Debt	124.58M
Net Cash	-38.46M
Net Cash Per Share	-2.12
Equity (Book Value)	556.22M
Book Value Per Share	33.31
Working Capital	234.60M

Cash Flow

In the last 12 months, operating cash flow was 14.17 million and capital expenditures -10.55 million, giving a free cash flow of 3.62 million.

Operating Cash Flow	14.17M
Capital Expenditures	-10.55M
Free Cash Flow	3.62M
FCF Per Share	0.20

Margins

Gross margin is 38.00%, with operating and profit margins of 13.41% and 7.85%.

Gross Margin	38.00%
Operating Margin	13.41%
Pretax Margin	10.26%
Profit Margin	7.85%
EBITDA Margin	18.24%
EBIT Margin	13.41%
FCF Margin	0.57%

Dividends & Yields

Onyx Biotec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.78%
Shareholder Yield	n/a
Earnings Yield	5.97%
FCF Yield	0.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6